SOLOXYLOMETAZOLIN, spray 140 mcg/dose 15 ml

Acute respiratory diseases with rhinitis (runny nose), acute allergic rhinitis, pollinosis, sinusitis, eustachitis, otitis media (to reduce nasopharyngeal mucosa edema).

Preparing the patient for diagnostic manipulations in the nasal passages.

Active ingredient

Composition

How to take, the dosage

Intranasally (in each nasal passage).

In children aged 2 to 6 years: 1 injection of Xylometazolin-SOLOPHARM Nasal Spray 35 µg/dose in each nasal passage; do not use more than 3 times a day.

Adults and children over 6 years of age: 1 injection of Xylometazoline – SOLOPHARM, nasal spray dosed 140 µg/dose in each nasal passage (may be repeated if necessary); do not use more than 3 times daily.

If symptoms worsen or do not improve within 3 days, a physician should be consulted. At the recommended dose without consulting a physician, use for no more than 7 days.

Doses above the recommended dose should only be used under a physician’s supervision.

In frequent and prolonged use, a “stuffy” feeling in the nose may reappear or worsen. If these symptoms occur, you should stop treatment and see a physician.

One 70 µL injection contains 35 µg xylometazoline hydrochloride – for Xylometazoline-SOLOfarm, nasal spray dispensed 35 µg/dose.

One 140 µL injection contains 140 µg xylometazoline hydrochloride – for Xylometazoline-SOLOpharm, 140 µg/dose nasal spray.

Interaction

Xylometazoline should not be used in patients receiving therapy with monoamine oxidase inhibitors and tricyclic antidepressants (including a period of 14 days after their withdrawal) due to the possibility of increased blood pressure.

Directions for use

Special Instructions

Avoid getting the drug in the eyes.

The drug should be used individually to avoid spreading infection.

The recommended doses should not be exceeded and the drug should not be used for prolonged periods (more than 7 days). Prolonged use of the drug may cause a “ricochet” effect (rhinitis medica), increasing the risk of reactive hyperemia and atrophy of the nasal mucosa.

Because the drug contains benzalkonium chloride as a preservative, especially with prolonged use (more than 7 days), nasal mucosal edema may develop. If there is suspicion of such a reaction (nasal congestion), it is necessary, if possible, to use a drug that does not contain preservatives. If such medications are not available, another form of medication should be used.

Impact on ability to drive:

Xylomethasoline may affect the ability to operate vehicles or equipment.

When treating with the drug, caution should be exercised when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and quick psychomotor actions.

Synopsis

Contraindications

Side effects

In frequent and/or prolonged use – irritation and/or dry nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion of nasopharyngeal mucosa, hypersensitivity reactions, nasal mucosa edema, palpitations, tachycardia, arrhythmia, increased blood pressure, headache, nausea, vomiting, insomnia, visual disturbances, depression (with prolonged use of high doses).

If any of the side effects listed in the instructions worsen, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose

Symptoms: increased side effects (dose-dependent), decreased body temperature, confusion. If ingested accidentally, the drug may cause: severe dizziness, increased sweating, headache, bradycardia, increased blood pressure, respiratory depression, coma and seizures. After a rise in blood pressure, there may be a sharp decrease in blood pressure.

Treatment: symptomatic.

Similarities